Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 35Recurrence 9Neoplasms 3Sarcoma, Kaposi 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multi-centric Castleman's Disease 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Chromosome 17 deletion 1Alzheimer Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

pomalidomide 1liposomal doxorubicin 1fludarabine phosphate 1fludarabine 1Thiotepa 1Tacrolimus 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Cyclophosphamide 1Busulfan 1Anti-HIV Agents 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Acquired Immunodeficiency Syndrome × pomalidomide × Clear all
NCT02659930 2026-06-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
62 enrolled
Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡